Circulating Tumor Cells: Assay Development and Clinical Utility DVD
Circulating Tumor Cells (CTCs) have recently captured the spotlight because of their potential as prognostic markers for clinical management of cancer patients. Translation of CTC technologies into clinical practice requires progress in assay development and establishing clinical utility. This DVD features expert speakers from CHI’s Biomarker Assay Development 2010 meeting addressing novel approaches to CTC detection and profiling, as well as establishing clinical utility of CTCs for predicting disease progression and response to therapy. More info
ADAPT 2009 DVD's
Fit-For-Purpose Biomarker Assay Development
and Validation DVD
This course will provide recommendations on the “fit-for-purpose” best practices in the development and validation of biomarker assays for the intended exploratory or advanced biomarker applications. Strategies for different applications at various phases of biomarker development will be described. Key elements in method development and validation will be illustrated with examples, including reference to standard material, sample stability and collection integrity, validation and QC samples, validity of reference standards, calibration curve fitting methods, method optimization and method feasibility studies. The special challenges in protein biomarker assays will be discussed, including strategies for moving from biomarker panels in the exploratory phase to the few markers chosen to support clinical trials. Click here for more info
Personalized Medicine DVD
The “Personalized Medicine” DVD includes 10 presentations, providing a comprehensive overview of all angles of personalized medicine implementation from thought-leaders at big pharmaceutical and diagnostic companies, academia, FDA, NIST, insurance provider, law firm and the Personalized Medicine Coalition. The Personalized Medicine DVD offers a convenient multi-media format, allowing you to learn from the experts from the comfort of your own office and on your own schedule. Click here for more info
Coverage Includes:
Analytical and Biological Validation of Biomarkers
Multiplex Biomarker Assays
Protein Biomarker Assays
Circulating Tumor Cells
Novel Biomarker Assays for Cancer
Immunoassay Development
Monday, January 25, 2010
Fit-for-Purpose Biomarker Assay Development and Validation
(*Separate registration required)
Course Instructors:
John L. Allinson, FIBMS, Vice President, Biomarker Laboratory Services, ICON Development Solutions
Viswanath Devanarayan, Ph.D., Director, Global Exploratory Statistics, Abbott Laboratories
This tutorial will provide recommendations on the “fit-for-purpose” best practices in the development and validation of biomarker assays for the intended exploratory or advanced biomarker applications. Strategies for different applications at various phases of biomarker development will be described. Key elements in method development and validation will be illustrated with examples, including reference to standard material, sample stability and collection integrity, validation and QC samples, validity of reference standards, calibration curve fitting methods, method optimization and method feasibility studies. The special challenges in protein biomarker assays will be discussed, including strategies for moving from biomarker panels in the exploratory phase to the few markers chosen to support clinical trials.
Outline:
1. Introduction: Nomenclature, types of biomarker methods/assays, biomarker method development & validation road map, fundamental validity, similarity and differences from PK assays & diagnostic application
2. Pre-analytical and Bioanalytical elements: Target range, standards, validation & QC samples, stability, matrix effect, specificity, and relative selectivity
3. Calibration curve model selection, evaluation, and weighting
4. Method feasibility and optimization with precision profiles
5. Evaluation of some pre-study validation characteristics such as precision, bias, sensitivity and quantification limits
6. Use of sample controls for in-study performance monitoring and conformance testing among laboratories